The last two sessions have been pretty wild for U.S. Stem Cell, Inc. f/k/a Bioheart, Inc. (OTCMKTS:BHRT). First, on Monday, the ticker surged 54% up and it reached $0.0017 on strong volume. Trading was...
Bioheart, Inc. (OTCMKTS:BHRT) has not really had much luck as a public company. In fact, its story has been rather sad. It might seem a bit strange considering the current price of $0.004 per...
Bioheart, Inc. (OTCMKTS:BHRT) is a development stage biomedical company listed on the OTC Markets and if the latest press releases are anything to go by, they seem to be moving forward. On February 24,...
Apple Rush Company (OTCMKTS:APRU)’s stock rarely got dollar volumes about $50 thousand, but was cradually ascending the charts in the past month. There were of course some sessions in the red, however, things were...
The last days of March are a wild run for Bioheart, Inc. (OTC:BHRT), each day marking a record or a near-record of buying and selling. Although the last fall was a cautious 2.5% on...